elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38857067-292BD976-AD40-435B-9E66-7D6DB36E0249
Q38857067-292BD976-AD40-435B-9E66-7D6DB36E0249
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-292BD976-AD40-435B-9E66-7D6DB36E0249
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
P2860
Q38857067-292BD976-AD40-435B-9E66-7D6DB36E0249
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-292BD976-AD40-435B-9E66-7D6DB36E0249
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e2959faebb7de532c51a672e0c1e2e28e00df8d
P2860
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)